{"id":"sgt-003","safety":{"commonSideEffects":[{"rate":"null","effect":"Muscle pain"},{"rate":"null","effect":"Muscle weakness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the use of adeno-associated virus (AAV) vectors to deliver the dystrophin gene to the muscle cells, where it can be expressed and help restore muscle function in patients with Duchenne muscular dystrophy.","oneSentence":"SGT-003 is a gene therapy that aims to deliver a functional dystrophin gene to muscle cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:15.216Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Duchenne muscular dystrophy"}]},"trialDetails":[{"nctId":"NCT07160634","phase":"PHASE3","title":"A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)","status":"RECRUITING","sponsor":"Solid Biosciences Inc.","startDate":"2025-10-22","conditions":"Duchenne Muscular Dystrophy","enrollment":80},{"nctId":"NCT06138639","phase":"PHASE1, PHASE2","title":"A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)","status":"RECRUITING","sponsor":"Solid Biosciences Inc.","startDate":"2024-05-06","conditions":"Duchenne Muscular Dystrophy","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SGT-003","genericName":"SGT-003","companyName":"Solid Biosciences Inc.","companyId":"solid-biosciences-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SGT-003 is a gene therapy that aims to deliver a functional dystrophin gene to muscle cells. Used for Duchenne muscular dystrophy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}